Jackson, Grant Investment Advisers, Inc. Astrazeneca PLC Transaction History
Jackson, Grant Investment Advisers, Inc.
- $295 Million
- Q3 2025
A detailed history of Jackson, Grant Investment Advisers, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Jackson, Grant Investment Advisers, Inc. holds 269 shares of AZN stock, worth $24,048. This represents 0.01% of its overall portfolio holdings.
Number of Shares
269
Previous 267
0.75%
Holding current value
$24,048
Previous $18,000
11.11%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...